Scorpion Venom Drug Biz Hit With SEC Fraud Suit
The U.S. Securities and Exchange Commission on Monday hit biopharmaceutical company Quanta and its CEO and executive vice president with a suit accusing the company of financial fraud over a 2021...To view the full article, register now.
Already a subscriber? Click here to view full article